Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03026647

Suture Material for Closure of Hysterotomy

Evaluation of Suture Material for Closure of Hysterotomy

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
St. Louis University · Academic / Other
Sex
Female
Age
14 Years – 55 Years
Healthy volunteers

Summary

Retrospective chart review evaluating different suture types on surgical outcomes for cesarean delivery and vaginal birth after cesarean delivery outcomes when different sutures are used.

Detailed description

Cesarean sections are one of the most common surgeries performed in the United States; approximately 1 out of 3 births are completed by cesarean delivery. In 2014, 1,284,551 cesarean deliveries were performed. Unfortunately, even with this being a very common procedure some surgical topics have not been fully evaluated. One of these topics is the choice of suture for repair of the hysterotomy (uterine) incision. Several suture materials are available, yet only polygatactin-910 and catgut have been evaluated in a single study. In this study, only surgery complications were evaluated. Catgut was found to be associated with less risk of receiving a blood transfusion, otherwise no differences were found. One of the most common suture materials used at our institution is poliglecaprone 25, however no long term studies have been completed for this indication. In addition, no studies have evaluated the risk of uterine rupture with trial of labor after cesarean after using poliglecaprone 25 to repair the hysterotomy. This information could be very useful in counseling for patients. As the cesarean delivery rates continue to climb, information on appropriate technique for surgery are needed.

Conditions

Interventions

TypeNameDescription
PROCEDURESutureTo examine different types of suture material used for hysterotomy closure in cesarean section and determine if one is preferred above other types due to a complications profile.

Timeline

Start date
2017-01-31
Primary completion
2018-04-01
Completion
2018-05-01
First posted
2017-01-20
Last updated
2017-11-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03026647. Inclusion in this directory is not an endorsement.